HLA
TDOC icon

Hamilton Lane Advisors’s Teladoc Health TDOC Stock Holding History

Hamilton Lane Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-31,522
Closed -$2.89M – 93
2021
Q4 		$2.89M Buy
31,522
+9,917
+46% +$1.19M 0.37% 27
2021
Q3 		$2.74M Sell
21,605
-3,768
-15% -$549K 0.46% 26
2021
Q2 		$4.22M Buy
25,373
+1,967
+8% +$319K 1.32% 19
2021
Q1 		$4.25M Buy
23,406
+6,648
+40% +$1.54M 1.39% 16
2020
Q4 		$3.35M Buy
+16,758
New +$3.41M 1.25% 18
2016
Q2 		– Sell
-17,604
Closed -$169K – 61
2016
Q1 		$169K Buy
+17,604
New +$250K 0.08% 54

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Hamilton Lane Advisors's TDOC Position: Q1 2022 in Review

Hamilton Lane Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 31,522 shares — an estimated $2.89M sold.

Hamilton Lane Advisors first reported a position in TDOC in Q1 2016 and held it in 6 quarters. The position peaked at $4.25M in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Hamilton Lane Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Hamilton Lane Advisors sold 31,522 Teladoc Health shares in Q1 2022, an estimated $2.89M.
  • Hamilton Lane Advisors first reported a position in Teladoc Health in Q1 2016 and held it in 6 quarters.
  • Hamilton Lane Advisors's Teladoc Health position peaked at $4.25M in Q1 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Hamilton Lane Advisors's 13F filing for Q1 2022, filed 4 May 2022.